Laserfiche WebLink
<br /> THE SCHEDULING PROCESS REQUIRES THE <br /> <br /> ADMINISTRATOR TO CONSIDER BOTH THE ABUSE, <br /> AND MEDICAL AND SCIENTIFIC EVLUATION OF A <br /> CONTROLLED SUBSTANCE, AS WELL AS PUBLIC <br /> OPINION VIA THE FEDERAL REGISTER, BEFORE <br /> ISSUING A FINAL RULING. <br /> THE DEA HAS ACCUMULATED SUFFICIENT DATA <br /> SURROUNDING THE ABUSE, TRAFFICKING, AND <br /> CLANDESTINE MANUFACTURING OF GHB. <br /> HOWEVER, AS PART OF THE OVERALL SCHEDULING <br /> PROCESS FOR ALL CONTROLLED SUBSTANCES, DEA <br /> MUST ALSO OBTAIN A SCIENTIFIC AND MEDICAL <br /> EVALUATION OF GHB. <br /> <br />